Literature DB >> 30648340

A new diagnostic index for sarcopenia and its association with short-term postoperative complications in patients undergoing surgery for colorectal cancer.

J Yang1, T Zhang1, D Feng1, X Dai1, T Lv1, X Wang1, J Gong1, W Zhu1, J Li1.   

Abstract

AIM: Sarcopenia is a robust prognostic indicator of outcomes after surgery for colorectal cancer (CRC). However, there are no serum markers routinely available for estimating skeletal muscle mass (SMM). The present study aimed to describe a new sarcopenia index (SI), serum creatinine (Scr) × cystatin C-based glomerular filtration rate, and investigate its association with short-term complications after curative resection of CRC.
METHOD: Consecutive patients who underwent curative resection of CRC from December 2011 to January 2017 were retrospectively identified. Skeletal muscle cross-sectional area was analysed on L3 computed tomographic images. Receiver operating characteristic curve analysis showed that the cutoff points of SI for sarcopenia were below 56.1 in men and below 43.7 in women. Patients were classified into low and high SI groups in accordance with these cutoff values. The association between SI and body composition and the impact of preoperative SI on postoperative outcomes were analysed.
RESULTS: Among 417 patients, SI showed a stronger correlation with skeletal muscle area (SMA) (r = 0.537, P < 0.001) than with the Scr/cystatin C ratio (r = 0.469, P < 0.001) and Scr (r = 0.447, P < 0.001). The low SI group had a lower SMA, lower preoperative haemoglobin, a higher prevalence of sarcopenia and experienced more postoperative complications compared with the high SI group (all P < 0.001). Multivariate logistic regression analysis showed that the independent risk factors for overall complications were low preoperative haemoglobin, low SI, sarcopenia and American Society of Anesthesiologists grade ≥ 3.
CONCLUSION: This new SI is a simple and useful surrogate marker for estimating SMM, and is associated with outcomes after CRC surgery. Colorectal Disease
© 2019 The Association of Coloproctology of Great Britain and Ireland.

Entities:  

Keywords:  Skeletal muscle depletion; colorectal cancer; postoperative morbidity; sarcopenia index

Year:  2019        PMID: 30648340     DOI: 10.1111/codi.14558

Source DB:  PubMed          Journal:  Colorectal Dis        ISSN: 1462-8910            Impact factor:   3.788


  10 in total

1.  Sarcopenia HIBA score predicts sarcopenia and mortality in patients on the liver transplant waiting list.

Authors:  Ezequiel Mauro; Juan Manuel Diaz; Lucrecia Garcia-Olveira; Juan Carlos Spina; Lorena Savluk; Fernanda Zalazar; Julia Saidman; Martin De Santibañes; Juan Pekolj; Eduardo De Santibañes; Gonzalo Crespo; Juan G Abraldes; Adrían Gadano
Journal:  Hepatol Commun       Date:  2022-03-03

2.  A Novel Application of Serum Creatinine and Cystatin C to Predict Sarcopenia in Advanced CKD.

Authors:  Yu-Li Lin; Chih-Hsien Wang; I-Chen Chang; Bang-Gee Hsu
Journal:  Front Nutr       Date:  2022-02-25

3.  Serum creatinine to cystatin C ratio reflects preoperative and early postoperative walking ability in older patients with hip fracture.

Authors:  Naoki Okubo; Takashi Yoshida; Kazuya Tanaka; Naoya Okada; Kunihiko Hosoi; Masato Ohara; Kenji Takahashi
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-02-15       Impact factor: 12.910

4.  Serum creatinine/cystatin C ratio as a screening tool for sarcopenia and prognostic indicator for patients with esophageal cancer.

Authors:  Chao Zheng; Ellen Wang; Jiang-Shan Li; Kai Xie; Chao Luo; Qi-Yue Ge; Li-Wen Hu; Yi Shen
Journal:  BMC Geriatr       Date:  2022-03-15       Impact factor: 3.921

5.  Serum creatinine and cystatin C-based diagnostic indices for sarcopenia in advanced non-small cell lung cancer.

Authors:  Tianjiao Tang; Lingling Xie; Song Hu; Lingling Tan; Xiaozhen Lei; Xiaozhen Luo; Ling Yang; Ming Yang
Journal:  J Cachexia Sarcopenia Muscle       Date:  2022-03-17       Impact factor: 12.063

6.  Influence of Postoperative Changes in Sarcopenia on Long-Term Survival in Non-Metastatic Colorectal Cancer Patients.

Authors:  Chungyeop Lee; In-Ja Park; Kyung-Won Kim; Yongbin Shin; Seok-Byung Lim; Chan-Wook Kim; Yong-Sik Yoon; Jong-Lyul Lee; Chang-Sik Yu; Jin-Cheon Kim
Journal:  Cancers (Basel)       Date:  2021-05-17       Impact factor: 6.639

7.  CT-assessed sarcopenia is a predictive factor for both long-term and short-term outcomes in gastrointestinal oncology patients: a systematic review and meta-analysis.

Authors:  Huaiying Su; Junxian Ruan; Tianfeng Chen; Enyi Lin; Lijing Shi
Journal:  Cancer Imaging       Date:  2019-12-03       Impact factor: 3.909

8.  The emerging role of sarcopenia as a prognostic indicator in patients undergoing abdominal wall hernia repairs: a systematic review of the literature.

Authors:  S T Clark; G Malietzis; T N Grove; J T Jenkins; A C J Windsor; C Kontovounisios; O J Warren
Journal:  Hernia       Date:  2020-04-16       Impact factor: 4.739

9.  Preoperative Sedentary Time Predicts Postoperative Complications in Gastrointestinal Cancer.

Authors:  Takuya Yanagisawa; Hideshi Sugiura; Noriatsu Tatematsu; Mioko Horiuchi; Saki Migitaka; Keita Itatsu
Journal:  Asian Pac J Cancer Prev       Date:  2020-11-01

10.  Serum creatinine/cystatin C ratio as a surrogate marker for sarcopenia in patients with gastric cancer.

Authors:  Jing Sun; Hui Yang; Wentao Cai; Jingwei Zheng; Ningzhe Shen; Xinxin Yang; Bujian Pan; Weiteng Zhang; Xiaodong Chen; Xian Shen
Journal:  BMC Gastroenterol       Date:  2022-01-19       Impact factor: 3.067

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.